BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18487947)

  • 1. JSI-124 inhibits glioblastoma multiforme cell proliferation through G(2)/M cell cycle arrest and apoptosis augment.
    Su Y; Li G; Zhang X; Gu J; Zhang C; Tian Z; Zhang J
    Cancer Biol Ther; 2008 Aug; 7(8):1243-9. PubMed ID: 18487947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of cucurbitacin E on GADD45β-trigger G2/M arrest and JNK-independent pathway in brain cancer cells.
    Cheng AC; Hsu YC; Tsai CC
    J Cell Mol Med; 2019 May; 23(5):3512-3519. PubMed ID: 30912292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the NF-κB pathway by the STAT3 inhibitor JSI-124 in human glioblastoma cells.
    McFarland BC; Gray GK; Nozell SE; Hong SW; Benveniste EN
    Mol Cancer Res; 2013 May; 11(5):494-505. PubMed ID: 23386688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JSI-124 (cucurbitacin I) inhibits Janus kinase-3/signal transducer and activator of transcription-3 signalling, downregulates nucleophosmin-anaplastic lymphoma kinase (ALK), and induces apoptosis in ALK-positive anaplastic large cell lymphoma cells.
    Shi X; Franko B; Frantz C; Amin HM; Lai R
    Br J Haematol; 2006 Oct; 135(1):26-32. PubMed ID: 16939498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.
    Blaskovich MA; Sun J; Cantor A; Turkson J; Jove R; Sebti SM
    Cancer Res; 2003 Mar; 63(6):1270-9. PubMed ID: 12649187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cucurbitacin-I (JSI-124) activates the JNK/c-Jun signaling pathway independent of apoptosis and cell cycle arrest in B leukemic cells.
    Ishdorj G; Johnston JB; Gibson SB
    BMC Cancer; 2011 Jun; 11():268. PubMed ID: 21702955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foretinib induces G2/M cell cycle arrest, apoptosis, and invasion in human glioblastoma cells through c-MET inhibition.
    Gortany NK; Panahi G; Ghafari H; Shekari M; Ghazi-Khansari M
    Cancer Chemother Pharmacol; 2021 Jun; 87(6):827-842. PubMed ID: 33688998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JSI-124 Induces Cell Cycle Arrest and Regulates the Apoptosis in Glioblastoma Cells.
    Tsai TH; Lee KT; Hsu YC
    Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38001999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase.
    Li W; Liu J; Fu W; Zheng X; Ren L; Liu S; Wang J; Ji T; Du G
    J Exp Clin Cancer Res; 2018 Jul; 37(1):132. PubMed ID: 29970196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JSI-124 suppresses invasion and angiogenesis of glioblastoma cells in vitro.
    Yuan G; Yan S; Xue H; Zhang P; Sun J; Li G
    PLoS One; 2015; 10(3):e0118894. PubMed ID: 25789853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation.
    Luo D; Fraga-Lauhirat M; Millings J; Ho C; Villarreal EM; Fletchinger TC; Bonfiglio JV; Mata L; Nemesure MD; Bartels LE; Wang R; Rigas B; Mackenzie GG
    Carcinogenesis; 2019 Dec; 40(12):1480-1491. PubMed ID: 30994173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of constitutive activation of STAT3 by curcurbitacin-I (JSI-124) sensitized human B-leukemia cells to apoptosis.
    Ishdorj G; Johnston JB; Gibson SB
    Mol Cancer Ther; 2010 Dec; 9(12):3302-14. PubMed ID: 21159613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducement of mitosis delay by cucurbitacin E, a novel tetracyclic triterpene from climbing stem of Cucumis melo L., through GADD45γ in human brain malignant glioma (GBM) 8401 cells.
    Hsu YC; Chen MJ; Huang TY
    Cell Death Dis; 2014 Feb; 5(2):e1087. PubMed ID: 24577085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPR17 signaling activation by CHBC agonist induced cell death via modulation of MAPK pathway in glioblastoma.
    Nguyen P; Doan P; Murugesan A; Ramesh T; Rimpilainen T; Candeias NR; Yli-Harja O; Kandhavelu M
    Life Sci; 2022 Feb; 291():120307. PubMed ID: 35016881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-124 Acts as a Tumor Suppressor in Glioblastoma via the Inhibition of Signal Transducer and Activator of Transcription 3.
    Li W; Huang H; Su J; Ji X; Zhang X; Zhang Z; Wang H
    Mol Neurobiol; 2017 May; 54(4):2555-2561. PubMed ID: 26993295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jaceosidin induces p53-dependent G2/M phase arrest in U87 glioblastoma cells.
    Khan M; Rasul A; Yi F; Zhong L; Ma T
    Asian Pac J Cancer Prev; 2011; 12(12):3235-8. PubMed ID: 22471459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
    Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
    Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated delivery of bFGF small interfering RNA reduces STAT3 phosphorylation and induces the depolarization of mitochondria and apoptosis in glioma cells U251.
    Liu J; Xu X; Feng X; Zhang B; Wang J
    J Exp Clin Cancer Res; 2011 Sep; 30(1):80. PubMed ID: 21906308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cucurbitacin B markedly inhibits growth and rapidly affects the cytoskeleton in glioblastoma multiforme.
    Yin D; Wakimoto N; Xing H; Lu D; Huynh T; Wang X; Black KL; Koeffler HP
    Int J Cancer; 2008 Sep; 123(6):1364-75. PubMed ID: 18561312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of CDC2 expression inhibits proliferation, enhances apoptosis, and increases chemosensitivity to temozolomide in glioblastoma cells.
    Zhou B; Bu G; Zhou Y; Zhao Y; Li W; Li M
    Med Oncol; 2015 Jan; 32(1):378. PubMed ID: 25433945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.